Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus (Q41005537)

25 September 2017

Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus (English)

1 reference

25 September 2017

1 reference

1 reference

Delaney WE 4th

1

1 reference

PubMed ID

9755254

25 September 2017

Isom HC

series ordinal

2

1 reference

PubMed ID

9755254

25 September 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

25 September 2017

1 reference

25 September 2017

28

1 reference

25 September 2017

4

1 reference

25 September 2017

1134-1146

1 reference

Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan

25 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Comparative sequence analysis of duck and human hepatitis B virus genomes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Major differences between WHV and HBV in the regulation of transcription

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Stable expression and replication of hepatitis B virus genome in an integrated state in a human hepatoma cell line transfected with the cloned viral DNA

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

The HBV-producing cell line HepG2-4A5: a new in vitro system for studying the regulation of HBV replication and for screening anti-hepatitis B virus drugs

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Classification and nomenclature of viruses. Fourth report of the International Committee on Taxonomy of Viruses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Strong and Regulated Expression of Escherichia coli β-Galactosidase in Insect Cells with a Baculovirus Vector

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Genetically engineered baculoviruses as agents for pest control

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Gene transfer into hepatocytes and human liver tissue by baculovirus vectors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Baculovirus-mediated gene transfer into mammalian cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Efficient gene transfer into human hepatocytes by baculovirus vectors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

High-level hepatitis B virus replication in transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Replication of duck hepatitis B virus in two differentiated human hepatoma cell lines after transfection with cloned viral DNA.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Relationship between viral DNA synthesis and virion envelopment in hepatitis B viruses.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

The proteins of hepatitis B dane particle cores

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitro

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

In vitro inhibition of hepatitis B virus replication by 2',3'-dideoxyguanosine, 2',3'-dideoxyinosine, and 3'-azido-2',3'-dideoxythymidine in 2.2.15 (PR) cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Inhibitory effects of acyclic nucleoside phosphonates on human hepatitis B virus and duck hepatitis B virus infections in tissue culture

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Pure nucleoside enantiomers of beta-2',3'-dideoxycytidine analogs are selective inhibitors of hepatitis B virus in vitro

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Phyllanthus amarus down-regulates hepatitis B virus mRNA transcription and replication

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Production of hepatitis B virus covalently closed circular DNA in transfected cells is independent of surface antigen synthesis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Enhanced core protein production by hepatitis B virus bearing a mutation in the precore region

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Activating transcription factor 2 (ATF2) down-regulates hepatitis B virus X promoter activity by the competition for the activating protein 1 binding site and the formation of the ATF2-Jun heterodimer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Promoters for synthesis of the pre-C and pregenomic mRNAs of human hepatitis B virus are genetically distinct and differentially regulated

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Reduced antigen production by hepatitis B virus harbouring nucleotide deletions in the overlapping X gene and precore-core promoter

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Effects of mutations within and adjacent to the terminal repeats of hepatitis B virus pregenomic RNA on viral DNA synthesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Expression and replication of hepatitis B virus genome in transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

High-efficiency transformation of mammalian cells by plasmid DNA

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

HCV cDNA transfection to HepG2 cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Lipid-mediated transfection of normal adult human hepatocytes in primary culture

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510280432

7 January 2021

Identifiers

DOI

10.1002/HEP.510280432

1 reference

25 September 2017

1 reference

PubMed ID

9755254